expanding role of trop2-directed adcs in mbc management — sara m tolaney, md, mph
Published 3 weeks ago • 40 plays • Length 28:21Download video MP4
Download video MP3
Similar videos
-
1:02:35
integrating antibody-drug conjugates into mgmt of hr and triple-negative metastatic breast cancer
-
10:40
q&a -discussing multi modality two2 therapy
-
5:30
antibody drug conjugates of trastuzumab for her2 mbc
-
19:16
su2 conference 23: extending composition-dependent fluid model for compressible multi-component flow
-
![[quality] q3d(r2)](https://i.ytimg.com/vi/VKZ51KBPGqY/mqdefault.jpg)
35:20
[quality] q3d(r2)
-
49:56
reshaping the future of lung cancer treatment with trop2-targeting adcs and rational combinations
-
4:40
enos (sports): multi-articulating robotic surgery system
-
11:48
multilab 2cp r assembly unetixs vascular
-
5:38
med2rdf project for biomedical data integration @ biohackathon2019
-
56:23
are you prepared for the new wave of adcs in nsclc? targeting her2, her3, trop2, and others
-
3:18
(한글자막) nebnext ultra ii directional rna workflow
-
1:21
additional functions dehidratation advance eng
-
0:42
injecta - fill-finish machine for nested rtu components.
-
10:49
ddf connection showcase - trials.ai demo
-
1:25
dato-dxd: a new adc on the block
-
4:00
adcs on the horizon for breast cancer: managing treatment-emergent toxicities
-
12:05
conversations in advanced nsclc - impact of adcs
-
5:00
hematologic adverse events with adcs in breast cancer: optimal management strategies
-
32:30
chairperson perspective: precision payloads: exploring adc-directed therapies in her2-mutant and ...